You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PEG-Intron

Showing 1 - 25 of 927
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

Recruiting
  • Hematological Neoplasms
  • Recurrence
  • Peg interferon alfa-2b
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021

Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

Completed
Has Results
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas
  • Pegylated interferon alpha-2b
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Jan 18, 2022

Advanced Cholangiocarcinoma Trial in Washington (Pembrolizumab, Sylatron)

Terminated
Has Results
  • Advanced Cholangiocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Feb 14, 2022

Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)

Active, not recruiting
Has Results
  • Malignant Melanoma
  • Peginterferon alfa-2b
  • +2 more
  • San Diego, California
  • +2 more
Apr 1, 2022

HIV Trial in United States (Peginterferon alfa-2b)

Completed
  • HIV Infections
  • Peginterferon alfa-2b
  • Long Beach, California
  • +14 more
Oct 28, 2021

Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)

Completed
  • Chronic Hepatitis C Virus Infection
  • P1101 + Ribavirin
  • PEG-Intron + Ribavirin
  • Beijing, China
  • +38 more
Jan 14, 2022

Hepatitis C, Chronic Trial (Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c)

Completed
  • Hepatitis C, Chronic
  • Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin
  • Combination of (a) pegylated interferon alfa-2b and (b) ribavirin
  • (no location specified)
Aug 24, 2020

Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

Completed
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Aug 26, 2021

Melanoma Trial in Houston (Temozolomide (TMZ), Pegylated Interferon Alpha-2b (PGI))

Completed
Has Results
  • Melanoma
  • Temozolomide (TMZ)
  • Pegylated Interferon Alpha-2b (PGI)
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 1, 2020

Chronic Myelogenous Leukemia Trial (Pegylated interferon alfa-2b, Interferon alfa-2b)

Terminated
Has Results
  • Chronic Myelogenous Leukemia
  • Pegylated interferon alfa-2b
  • Interferon alfa-2b
  • (no location specified)
Jul 12, 2019

Melanoma Trial (PEG-Intron, INTRON A)

Terminated
Has Results
  • Melanoma
  • PEG-Intron
  • INTRON A
  • (no location specified)
Jul 16, 2019

Tumors Trial (PEG Interferon Alfa-2b, Acetaminophen)

Completed
Has Results
  • Neoplasms
  • (no location specified)
Jul 12, 2019

Hepatitis C Trial (PEG-Intron, Interferon Alfa-2B)

Completed
Has Results
  • Hepatitis C
  • PEG-Intron
  • Interferon Alfa-2B
  • (no location specified)
Jan 10, 2019

Melanoma Trial in Napoli (Vemurafenib, Peg-interferon, Cobimetinib)

Completed
  • Melanoma
  • Napoli, Italy
    Fondazione G.Pascale
Feb 23, 2022

Leukemia, Myeloid, Philadelphia-Positive Trial in Houston (PEG-Intron)

Terminated
  • Leukemia, Myeloid, Philadelphia-Positive
  • PEG-Intron
  • Houston, Texas
    M. D. Anderson Cancer Center
Oct 31, 2018

Lymphoma Trial in Chicago (Pegylated interferon a-2b, Psoralens with ultraviolet light A, Narrowband-ultraviolet light B)

Terminated
Has Results
  • Lymphoma
  • Pegylated interferon α-2b
  • +2 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Nov 20, 2018

Leukemia Trial in Houston (Peptide Vaccine (PR1 Peptide), Peginterferon alfa-2b, Imatinib)

Terminated
Has Results
  • Leukemia
  • Peptide Vaccine (PR1 Peptide)
  • +3 more
  • Houston, Texas
    UT MD . Anderson Cancer Center
Jul 23, 2018

Melanoma Trial in Houston (Decitabine, Pegylated Interferon Alpha-2b)

Terminated
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 7, 2018

Kidney Cancer Trial in Charleston (PEG-interferon alfa-2b, GM-CSF, thalidomide)

Terminated
Has Results
  • Kidney Cancer
  • PEG-interferon alfa-2b
  • +2 more
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Jun 13, 2018

PEGylated GH for Treatment of Short Stature in Chinese

Recruiting
  • Growth Hormone Treatment
  • Growth Disorders
  • Polyethylene glycol recombinant human growth hormone injection
  • Beijing, Beijing, China
    Department of Endocrinology, Genetics, Metabolism
Sep 12, 2023

Predictive Models of Inadequate Colonic Preparation

Not yet recruiting
  • Cleansing Quality of the Colon
  • Bowel preparation for colonoscopy
  • Colonoscopic examination
  • (no location specified)
May 13, 2023

Leber Congenital Amaurosis 10, Inherited Retinal Dystrophies, Eye Diseases, Hereditary Trial in United States (EDIT-101)

Active, not recruiting
  • Leber Congenital Amaurosis 10
  • +6 more
  • Miami, Florida
  • +4 more
Dec 2, 2022

Colonoscopy Trial in Chendu (100 ml lactulose combined with 1 L PEG, 100 ml lactulose combined with 2 L PEG, 200 ml lactulose)

Completed
  • Colonoscopy
  • 100 ml lactulose combined with 1 L PEG
  • +3 more
  • Chendu, Sichuan, China
    west china fourth hospital of Sichuan university
Dec 29, 2022

Nonalcoholic Steatohepatitis (NASH) Trial in Taiwan (ADI-PEG20, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Kaohsiung, Taiwan
  • +4 more
Apr 24, 2023

Non-Hodgkins Lymphoma Trial (CHOP/Rituximab, PEG INTRON)

Completed
  • Non-Hodgkins Lymphoma
  • (no location specified)
Jan 22, 2018